Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Rev Med Interne ; 39(7): 546-550, 2018 Jul.
Artículo en Francés | MEDLINE | ID: mdl-29789192

RESUMEN

BACKGROUND: Adverse events related to vitamin K antagonists (VKA) represent a major public health problem. Informative tools and educative program contributes to the reduction of iatrogenic risk. The purpose of our study is to assess representations and information needs of patients under VKA therapy in order to develop a suitable therapeutic education program. METHODS: Individual semi-structured interviews were conducted among both long term VKA therapy patient and patients initiating VKA. The thematic analysis allowed us to explore patient's speech qualitatively and semi-quantitatively. RESULTS: The main needs in information concerned the modalities of treatment (27.6%), side effects (24.1%), precautions and management of VKA treatment (24.1%). Origin of the disease (P=0.022) and drug mechanism of action (0.012) were specially asked about by patients initiating their treatment. CONCLUSION: Patients under VKA therapy reported needs for information on both their pathology and their anticoagulant therapy. The therapeutic education approach will enable us to adapt the educational tools and messages to the needs of patients under VKA therapy.


Asunto(s)
4-Hidroxicumarinas/uso terapéutico , Anticoagulantes/uso terapéutico , Trastornos de la Coagulación Sanguínea/tratamiento farmacológico , Indenos/uso terapéutico , Evaluación de Necesidades , Educación del Paciente como Asunto , Vitamina K/antagonistas & inhibidores , 4-Hidroxicumarinas/efectos adversos , Adulto , Anciano , Anciano de 80 o más Años , Anticoagulantes/efectos adversos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/etiología , Femenino , Humanos , Indenos/efectos adversos , Difusión de la Información/métodos , Masculino , Persona de Mediana Edad , Prioridad del Paciente/estadística & datos numéricos , Vitamina K/efectos adversos , Vitamina K/uso terapéutico
2.
Egypt Heart J ; 70(1): 45-49, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29622997

RESUMEN

BACKGROUND: Vitamin K antagonists are widely used in the treatment and prevention of thromboembolic disease. However, these drugs can cause serious side effects, especially bleeding. This study aims to evaluate frequency and risk factors of both bleeding and asymptomatic overdose in North African patients undergoing Vitamin K antagonist therapy. METHODS: We performed a cross-sectional study in patients undergoing Vitamin K antagonist therapy. A statistical analysis has been conducted to identify overdose and bleeding risk factors by using chi-square test (p < .05). RESULTS: One hundred and eleven patients were included. We recorded 14 cases of bleeding and 26 cases of asymptomatic overdose. Advanced age, poor adherence, concomitant use of paracetamol and history of previous bleeding are significant risk factors of over-anticoagulation. An INR value over 6 at admission, a high therapeutic target range for INR, concomitant use of acetylsalicylic acid, lack of information on overdose signs and measures to be taken in case of bleeding were identified as risk factors for bleeding. CONCLUSION: Most of the risk factors identified in our study seem to be related to patients lack of information and education. These results highlight the importance of creating a therapeutic patient education program.

3.
Ann Cardiol Angeiol (Paris) ; 67(1): 41-47, 2018 Feb.
Artículo en Francés | MEDLINE | ID: mdl-28318516

RESUMEN

INTRODUCTION: Venous thromboembolism is a multicausal disease. Understanding interactions between risk factors is the key to advance knowledge about the etiology of venous thrombosis. These interactions are still unclear. In addition to traditional risk factors, there is data about many other risk factors, recorded with few populations based prospective epidemiologic studies or punctually reported. Interactions between these risk factors remain unclear. The aim of our work is to identify and analyze combinations of risk factors. METHODS: This is a retrospective, single-center study, which investigates the etiology of venous thromboembolism, on the records of patients hospitalized in internal medicine for venous thrombosis, over a period of 12 years. RESULTS: We selected 276 cases. The average age was 51 years. At least, we found one traditional risk factors in 87 % of cases, 34 patients had no traditional risk factors. Suspected risk factors were found in 81 % of cases and there was at least one punctually reported factor in 34 % of cases. The combination of risk factors mostly found was association of traditional and suspected risk factors. In more than 50 % of patients, we noted at least, more than one traditional or one suspected risk factors. Among 18 patients presenting only suspected risk factors, there was at least combination of 3 risk factors per patient. CONCLUSION: The role of suspected risk factors in the occurrence of venous thrombosis was not negligible in this work. Our data suggest a hypothesis that it's through their association that suspected risk factors might be able becoming comparable to traditional risk factors.


Asunto(s)
Tromboembolia Venosa/epidemiología , Adolescente , Adulto , África del Norte/epidemiología , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Femenino , Humanos , Masculino , Persona de Mediana Edad , Obesidad/epidemiología , Prevalencia , Estudios Retrospectivos , Factores de Riesgo , Tromboembolia Venosa/diagnóstico
4.
Rev Med Brux ; 38(3): 152-153, 2017.
Artículo en Francés | MEDLINE | ID: mdl-28653516

RESUMEN

The association between Sweet syndrome and monoclonal gammopathy of undetermined significance (MGUS) is exceptional. We report the case of a 44 years-old woman in whom recurrent Sweet syndrome was complicated by monoclonal gammopathy of undetermined significance (MGUS) after 3 years of evolution.


L'association entre syndrome de Sweet et gammapathies monoclonales de signification indéterminée (MGUS) est exceptionnelle. Nous rapportons l'observation d'une patiente âgée de 44 ans chez qui un syndrome de Sweet d'évolution récurrente, s'est compliqué par l'apparition d'une gammapathie monoclonale de signification indéterminé après 3 ans d'évolution.

7.
Med Sante Trop ; 25(4): 414-8, 2015.
Artículo en Francés | MEDLINE | ID: mdl-26039888

RESUMEN

AIM: Cryoglobulinemia is characterized by multiple organ involvement, mainly including the skin, liver, kidneys, and peripheral nerves. Our aim was to investigate the demographic, clinical, and serologic features, as well as survival in a group of 16 Tunisian patients with cryoglobulinemia. RESULTS: The study included 12 women and 4 men, and their mean age was 41 years. In all but two, the cryoglobulinemia was associated with another disease. These included lupus for 9, Sjögren syndrome for 2, and polyarteritis nodosa for one. They also included infectious diseases: 3 patients with hepatitis B virus infection, one with hepatitis C virus infection, one with parvovirus B19, and another with lymph node tuberculosis. Only one case of lymphoproliferative disease was noted. General symptoms were present in 81% of the patients, cutaneous vasculitis in 43%, peripheral vascular-Raynaud phenomenon in 37%, joint polyarthralgia or arthritis in 62%, renal involvement in 68%, neuropathy in 25%, lung involvement in 56%, gastrointestinal involvement in 37%, and finally cardiac involvement in 31%. In some cases it was difficult to determine if the clinical signs were attributable to cryoglobulinemia or the underlying pathology. The course was favorable under treatment for 5 patients, while 7 patients became sicker and 5 finally died. CONCLUSION: Cryoglobulinemia is underdiagnosed. Treatment depends on the severity of the lesions and the underlying disease.


Asunto(s)
Crioglobulinemia , Adolescente , Adulto , Anciano , Crioglobulinemia/diagnóstico , Crioglobulinemia/terapia , Femenino , Humanos , Medicina Interna , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Túnez , Adulto Joven
8.
Pathol Biol (Paris) ; 61(6): 269-72, 2013 Dec.
Artículo en Francés | MEDLINE | ID: mdl-23849769

RESUMEN

OBJECTIVE: To study the maternal and fetal outcomes in women with systemic lupus erythematosus. PATIENTS AND METHODS: A retrospective study of 26 pregnancies in 15 systemic erythematosus patients diagnosed before or during pregnancy regarding to American College of Rheumatology criteria in a single reference center. RESULTS: The mean patient age was 31.52 years (24-39 years). The mean interval from the diagnosis of the systemic lupus erythematosus to pregnancy was 4.2 years. Eight pregnancies were planned. The flare rate of lupus during pregnancy was 31%, life birth rate was 65% and fetal loss rate was 35%. DISCUSSION AND CONCLUSION: As an increase in disease activity can occur during pregnancy and because of a higher rate of obstetrical complications in patients with lupus, it is important to carefully plan pregnancy. Pregnancy in lupus patients must be closely monitored by a multispeciality care of the patients.


Asunto(s)
Lupus Eritematoso Sistémico/epidemiología , Complicaciones del Embarazo/epidemiología , Resultado del Embarazo/epidemiología , Adulto , Femenino , Departamentos de Hospitales/estadística & datos numéricos , Humanos , Recién Nacido , Medicina Interna , Nacimiento Vivo/epidemiología , Lupus Eritematoso Sistémico/complicaciones , Embarazo , Complicaciones del Embarazo/etiología , Estudios Retrospectivos , Adulto Joven
9.
Artículo en Francés | MEDLINE | ID: mdl-23838248

RESUMEN

INTRODUCTION: Dental pain is a frequent reason for consulting. It may have non-odontogenic causes such as lesions of vascular, neurologic, muscular, or bone structures. The diagnosis and management of this acute or chronic pain syndrome may be difficult. We report a case of atypical dental pain leading to the diagnosis of a plasmocytic mandibular tumor revealing a multiple myeloma. CASE REPORT: A 50-year-old female patient consulted for dental pain during the 3 previous months. Bilateral mandibular swelling was noted during the clinical examination. Radiological examinations revealed a tumoral process associated with osteolytic lesions. The pathological examinations of biopsy samples revealed plasmocytic proliferation. A myelogram and immunoglobulin electrophoresis supported a diagnosis of multiple myeloma with kappa light chains. DISCUSSION: Discovering a mandibular tumor with lytic lesions is an indication for an etiological assessment and screening for a blood disease. A mandibular plasmacytoma may be isolated or present as a multiple myeloma, justifying a complete initial assessment. The bone localization of a plasmacytoma is a bad prognostic factor for survival for patients presenting with multiple myeloma.


Asunto(s)
Neoplasias Mandibulares/diagnóstico , Mieloma Múltiple/diagnóstico , Plasmacitoma/diagnóstico , Odontalgia/diagnóstico , Diagnóstico Diferencial , Femenino , Humanos , Neoplasias Mandibulares/complicaciones , Persona de Mediana Edad , Mieloma Múltiple/complicaciones , Plasmacitoma/complicaciones , Tomografía Computarizada por Rayos X , Odontalgia/etiología
11.
Rev Med Interne ; 29(1): 58-62, 2008 Jan.
Artículo en Francés | MEDLINE | ID: mdl-17936414

RESUMEN

INTRODUCTION: Langerhans cell histiocytosis of the thoracic spine is a rare condition in adults. It is a serious condition with an increased risk of spinal cord compression. EXEGESIS: A 55-year-old man complained of lumbar and back pain. He developed a spastic paraparesis. Magnetic resonance imaging of the spine showed a spinal cord compression due to bone and epidural tumoral lesions of the eleventh and twelfth thoracic vertebrae, located in the posterior elements of the spine. A surgical biopsy showed an infiltrate of eosinophilic cells, positive for CD1a in immunohistochemistry studies. Final diagnosis was therefore langerhans cell histiocytosis of the thoracic spine complicated by spinal cord compression. The patient received glucocorticoid therapy combined with vinblastine followed by local radiotherapy and etoposide. However, the neurological deficit persisted and the patient finally died. CONCLUSION: Langerhans cell histiocytosis is a rare cause of spinal cord compression.


Asunto(s)
Histiocitosis de Células de Langerhans/complicaciones , Compresión de la Médula Espinal/etiología , Enfermedades de la Columna Vertebral/complicaciones , Vértebras Torácicas , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Etopósido/uso terapéutico , Resultado Fatal , Glucocorticoides/uso terapéutico , Histiocitosis de Células de Langerhans/diagnóstico , Histiocitosis de Células de Langerhans/tratamiento farmacológico , Histiocitosis de Células de Langerhans/radioterapia , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Paraparesia Espástica/etiología , Compresión de la Médula Espinal/diagnóstico , Compresión de la Médula Espinal/tratamiento farmacológico , Compresión de la Médula Espinal/radioterapia , Enfermedades de la Columna Vertebral/diagnóstico , Enfermedades de la Columna Vertebral/tratamiento farmacológico , Enfermedades de la Columna Vertebral/radioterapia , Vinblastina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA